Robbins Chapter 5 Tables Flashcards
Autosomal Dominant Disorders affecting the Nervous system (4)
Huntington disease
Neurofibromatosis
Myotonic dystrophy
Tuberous Sclerosis
Autosomal Dominant Disorders affecting the Urinary system (1)
Polycystic kidney disease
Autosomal Dominant Disorders affecting the GI system (1)
Familial polyposis coli
Autosomal Dominant Disorders affecting the Hematopoietic system (2)
Hereditary spherocytosis
Von Willebrand Disease
Autosomal Dominant Disorders affecting the Skeletal system (4)
Marfan Syndrome
Ehlers-Danlos Syndrome
Osteogenesis Imperfecta
Achondroplasia
Autosomal Dominant Disorders affecting the Metabolic system (2)
Familial Hypercholesterolemia
Acute Intermittent Porphyria
Autosomal Recessive Disorders affecting the Metabolic system (9)
Cystic fibrosis Phenylketonuria Galactosemia Homocystinuria Lysosomal storage disease a1-antitrypsin deficiency Wilson disease Hemochromatosis Glycogen strorage diseases
Autosomal Recessive Disorders affecting the Hematopoietic system (2)
Sickle Cell anemia
Thalassemias
Autosomal Recessive Disorders affecting the Endocrine system (1)
Congenital adrenal hyperplasia
Autosomal Recessive Disorders affecting the Skeletal system (2)
Ehlers-Danlos syndrome
Alkaptonuria
Autosomal Recessive Disorders affecting the Nervous system (3)
Neurogenic muscular atrophies
Friedreich ataxia
Spinal muscular atrophy
X-linked Recessive Disorders affecting the Musculoskeletal system (1)
Duchenne muscular dystrophy
X-linked Recessive Disorders affecting the Blood system (3)
Hemophilia A and B
Chronic Granulomatous disease
Glucose-6-phosphate dehydrogenase deficiency
X-linked Recessive Disorders affecting the Immune system (2)
Agammaglobulinemia
Wiskott-Aldrich syndrome
X-linked Recessive Disorders affecting the Metabolic system (2)
Diabetes Insipidus
Lesch-Nyhan syndrome
X-linked Recessive Disorders affecting the Nervous system (1)
Fragile X Syndrome
Biochemical and Molecular basis for Phenylketonuria
enzyme problem: phenylalanine hydroxylase
splice-site mutation causing reduced amount of enzyme
Biochemical and Molecular basis for Tay-Sachs disease
enzyme problem: hexosminidase
splice-site mutation or frameshift mutation with stop codon causing reduced amount of enzyme
Biochemical and Molecular basis for Severe Combined Immunodeficiency
enzyme problem: adenosine deaminase
point mutations causing abnormal protein with reduced activity
Biochemical and Molecular basis for Emphysema and Liver disease
enzyme inhibitor problem: a1-antitrypsin
missense mutation causing impaired secretion from liver to serum
Biochemical and Molecular basis for Familial Hypercholesterolemia
receptor problem- LDL receptor
deletions, point mutations causing reduction of synthesis, transport to cell surface, or binding of LDL
Biochemical and Molecular basis for Vitamin D-resistant rickets
receptor problem- Vitamin D receptor
point mutations causing failure of normal signaling
Biochemical and Molecular basis for Alpha Thalassemia
transport of oxygen problem: hemoglobin
deletions causing reduced amount of oxygen transport
Biochemical and Molecular basis for Beta Thalassemia
transport of oxygen problem: hemoglobin
defective mRNA processing causing reduced amount of oxygen transport
Biochemical and Molecular basis for Sickle Cell Anemia
transport of oxygen problem: hemoglobin
point mutations causing abnormal structure of RBCs impairing oxygen transport
Biochemical and Molecular basis for Cystic Fibrosis
Ion channel transport problem: Cystic fibrosis transmembrane conductance regulator
deletions and other mutations causing nonfunctional or misfolded proteins
Biochemical and Molecular basis for Osteogenesis Imperfecta and Ehlers-Danlos syndromes
extracellular structural problem: collagen
deletions or point mutations cause reduced amount of normal collagen or normal amounts of defective collagen